Shawn McCarthy traded his vice president role at AngioDynamics Inc. (NSDQ:ANGO) for the corner office at Tryton Medical Inc., assuming the president and CEO spot at the Durham, N.C.-based stent maker.

McCarthy was senior vice president and general manager of AngioDynamics’ vascular and oncology surgery business units. AngioDynamics reported $12.3 million in net income on $216 million in sales last year. Tryton is a much smaller operation, posting $1.7 million to the top line in 2010.